1AD
Click for more information
0.00% 2.7¢ adalta limited

Countdown on to Adalta Trial Results, page-2

  1. investor901
    1,885 Posts.
    lightbulb Created with Sketch. 136
    clock Created with Sketch.
    13/02/24
    14:17
    Post #: 72382225
    what a waist of funds if that was its purpose. no article or webinar or ann brings any interest to SP.
    the only saviour is licensing deal. market is fed up of this CEO underdl delivering for years.
    we need a DXB catalyst.
    1AD Price at posting: 2.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.
HZR Hazer Group and POSCO team up to look at low carbon steel
right-arrow Created with Sketch.
TLX Telix testing shows efficacy of anti-prostate cancer therapy
right-arrow Created with Sketch.
IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
TLG Talga shows expansion options for Sweden's Vittangi graphite project
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.08M
Open High Low Value Volume
2.7¢ 2.7¢ 2.7¢ $405 15K

Buyers (Bids)

No. Vol. Price($)
4 1187032 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 737562 3
View Market Depth
Last trade - 10.00am 04/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.